Institution
University of Valencia
Education•Valencia, Spain•
About: University of Valencia is a education organization based out in Valencia, Spain. It is known for research contribution in the topics: Population & Context (language use). The organization has 27096 authors who have published 65669 publications receiving 1765689 citations. The organization is also known as: Universitat de València & UV.
Topics: Population, Context (language use), Neutrino, Medicine, Catalysis
Papers published on a yearly basis
Papers
More filters
••
TL;DR: A branch and bound algorithm for project scheduling with resource constraints based on the idea of using disjunctive arcs for resolving conflicts that are created whenever sets of activities have to be scheduled whose total resource requirements exceed the resource availabilities in some periods is described.
387 citations
••
Oslo University Hospital1, University College London2, University of Texas MD Anderson Cancer Center3, University of Valencia4, University of Technology, Sydney5, Vrije Universiteit Brussel6, University of Edinburgh7, University of Vic8, Princess Margaret Cancer Centre9, Haukeland University Hospital10, King's College London11, University Hospital Heidelberg12, Copenhagen University Hospital13, University of Lausanne14, University of Göttingen15
TL;DR: This Commission proposes the use of standardised care pathways and multidisciplinary teams to promote integration of oncology and palliative care, and calls for changes at the system level to coordinate the activities of professionals, and for the development and implementation of new and improved education programmes, with the overall goal of improving patient care.
Abstract: Full integration of oncology and palliative care relies on the specific knowledge and skills of two modes of care: the tumour-directed approach, the main focus of which is on treating the disease; and the host-directed approach, which focuses on the patient with the disease. This Commission addresses how to combine these two paradigms to achieve the best outcome of patient care. Randomised clinical trials on integration of oncology and palliative care point to health gains: improved survival and symptom control, less anxiety and depression, reduced use of futile chemotherapy at the end of life, improved family satisfaction and quality of life, and improved use of health-care resources. Early delivery of patient-directed care by specialist palliative care teams alongside tumour-directed treatment promotes patient-centred care. Systematic assessment and use of patient-reported outcomes and active patient involvement in the decisions about cancer care result in better symptom control, improved physical and mental health, and better use of health-care resources. The absence of international agreements on the content and standards of the organisation, education, and research of palliative care in oncology are major barriers to successful integration. Other barriers include the common misconception that palliative care is end-of-life care only, stigmatisation of death and dying, and insufficient infrastructure and funding. The absence of established priorities might also hinder integration more widely. This Commission proposes the use of standardised care pathways and multidisciplinary teams to promote integration of oncology and palliative care, and calls for changes at the system level to coordinate the activities of professionals, and for the development and implementation of new and improved education programmes, with the overall goal of improving patient care. Integration raises new research questions, all of which contribute to improved clinical care. When and how should palliative care be delivered? What is the optimal model for integrated care? What is the biological and clinical effect of living with advanced cancer for years after diagnosis? Successful integration must challenge the dualistic perspective of either the tumour or the host, and instead focus on a merged approach that places the patient's perspective at the centre. To succeed, integration must be anchored by management and policy makers at all levels of health care, followed by adequate resource allocation, a willingness to prioritise goals and needs, and sustained enthusiasm to help generate support for better integration. This integrated model must be reflected in international and national cancer plans, and be followed by developments of new care models, education and research programmes, all of which should be adapted to the specific cultural contexts within which they are situated. Patient-centred care should be an integrated part of oncology care independent of patient prognosis and treatment intention. To achieve this goal it must be based on changes in professional cultures and priorities in health care.
387 citations
••
University of Ioannina1, Sun Yat-sen University2, University of Ulsan3, National University of Malaysia4, National Taiwan University5, Mayo Clinic6, Zhejiang University7, Yonsei University8, Hospital Kuala Lumpur9, National Health Research Institutes10, University of Texas MD Anderson Cancer Center11, St. Marianna University School of Medicine12, Kanazawa University13, University of Valencia14, Hebron University15, Kobe University16
TL;DR: These guidelines represent the consensus opinions reached by experts in the treatment of patients with mCRC identified by the Presidents of the oncological societies of Japan (JSMO), China, Korea, Malaysia, Singapore, Singapore and Taiwan.
386 citations
••
TL;DR: The observed evolution of the Z(4430)^{-} amplitude with the ψ^{ fb^{-1} mass establishes the resonant nature of this particle.
Abstract: Resonant structures in B-0 -> psi'pi K--(+) decays are analyzed by performing a four-dimensional fit of the decay amplitude, using pp collision data corresponding to 3 fb(-1) collected with the LHCb detector. The data cannot be described with K+pi(-) resonances alone, which is confirmed with a model-independent approach. A highly significant Z(4430)(-) -> psi'pi(-) component is required, thus confirming the existence of this state. The observed evolution of the Z(4430)(-) amplitude with the psi'pi(-) mass establishes the resonant nature of this particle. The mass and width measurements are substantially improved. The spin parity is determined unambiguously to be 1(+).
386 citations
••
07 May 1998TL;DR: In this paper, a clear, accessible and up-to-date exposition of modular representation theory of finite groups from a character-theoretic viewpoint is presented. But the authors focus on the character theory of groups with a Sylow p-subgroup of order p.
Abstract: This is a clear, accessible and up-to-date exposition of modular representation theory of finite groups from a character-theoretic viewpoint. After a short review of the necessary background material, the early chapters introduce Brauer characters and blocks and develop their basic properties. The next three chapters study and prove Brauer's first, second and third main theorems in turn. These results are then applied to prove a major application of finite groups, the Glauberman Z*-theorem. Later chapters examine Brauer characters in more detail. The relationship between blocks and normal subgroups is also explored and the modular characters and blocks in p-solvable groups are discussed. Finally, the character theory of groups with a Sylow p-subgroup of order p is studied. Each chapter concludes with a set of problems. The book is aimed at graduate students, with some previous knowledge of ordinary character theory, and researchers studying the representation theory of finite groups.
384 citations
Authors
Showing all 27402 results
Name | H-index | Papers | Citations |
---|---|---|---|
H. S. Chen | 179 | 2401 | 178529 |
Alvaro Pascual-Leone | 165 | 969 | 98251 |
Sabino Matarrese | 155 | 775 | 123278 |
Subir Sarkar | 149 | 1542 | 144614 |
Carlos Escobar | 148 | 1184 | 95346 |
Marco Costa | 146 | 1458 | 105096 |
Carmen García | 139 | 1503 | 96925 |
Javier Cuevas | 138 | 1689 | 103604 |
M. I. Martínez | 134 | 1251 | 79885 |
Marco Aurelio Diaz | 134 | 1015 | 93580 |
Avelino Corma | 134 | 1049 | 89095 |
Kevin Lannon | 133 | 1652 | 95436 |
Marina Cobal | 132 | 1078 | 85437 |
Mogens Dam | 131 | 1109 | 83717 |
Marcel Vos | 131 | 993 | 85194 |